Vaccines Clinical Trials

A listing of Vaccines medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 126 clinical trials
featured
VAD00001: Respiratory Syncytial Virus (RSV) Study  

of baseline neutralizing antibody serostatus. To characterize the RSV-A serum neutralizing antibody responses to the study product in each vaccine group after vaccination in Respiratory

  • 0 views
  • 22 Jul, 2021
  • 17 locations
Efficacy Immunogenicity and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine

This study is a randomized, double-blinded, and active controlled phase III clinical trial of the SARS-CoV-2 inactivated vaccine. The purpose of this study is to evaluate the efficacy, safety

  • 0 views
  • 21 Jul, 2021
  • 1 location
Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years.

Primary Objective: To assess the immune response of the 3 SP0202 formulations, Prevnar 13 and Pneumovax 23 30 days after the administration of the single dose vaccination To assess the safety profile of the 3 SP0202 formulations, Prevnar 13 and Pneumovax 23

  • 0 views
  • 19 Jul, 2021
  • 11 locations
Safety and Efficacy Study of Meningococcal Group B Vaccine rMenB+OMV NZ (Bexsero) to Prevent Gonococcal Infection

This is a Phase II, randomized, observer-blind, placebo-controlled, multi-site trial of the FDA licensed rMenB+OMV NZ vaccine, Bexsero. The targeted study population is men and women 18-50 years

  • 0 views
  • 22 Jul, 2021
  • 7 locations
Covid-19 Vaccination in Adolescents

receiving the COVID-19 vaccines-BNT162b2, CoronaVac-chosen by the Hong Kong Government; to compare the reactogenicity and immunogenicity across the vaccines used for these children and their respective

  • 0 views
  • 22 Jul, 2021
  • 1 location
Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures

The aims of this vaccine trial are: (1) to measure humoral and selected cellular immune responses to repeated influenza vaccination with Flublok, including these responses' associations with age

influenza vaccination
trivalent influenza vaccine
quadrivalent inactivated influenza vaccine
vaccination
strain
  • 0 views
  • 10 Jul, 2021
  • 1 location
A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age

The primary goal for this study is to evaluate up to 3 dose levels of mRNA-1273 vaccine given to healthy children in 2 doses, 28 days apart.

  • 0 views
  • 21 Jul, 2021
  • 70 locations
Optimizing the Influenza Clinical Decision Support Tool

The proposed study aims to examine several iterations of the Influenza Best Practice Alert at NYU Langone Health. The goal is to increase ordering of the influenza vaccine through the alert.

  • 8 views
  • 17 Jul, 2021
  • 1 location
V114 and Acute Otitis Media (V114-032/PNEU-ERA)

The primary objective is to evaluate V114 in the prevention of vaccine-type acute otitis media (VT-AOM) and the safety of V114 with respect to the proportion of participants with serious adverse

  • 0 views
  • 21 Jul, 2021
  • 17 locations
Safety and Immunogenicity of an Intranasal RSV Vaccine Expressing SARS-CoV-2 Spike Protein (COVID-19 Vaccine) in Adults

This study evaluates an investigational vaccine that is designed to protect humans against infection with SARS-CoV-2, the novel coronavirus causing COVID-19 disease. The investigational vaccine

  • 0 views
  • 18 Jul, 2021
  • 2 locations